摘要
近年的研究显示,在心衰的发生发展过程中,神经内分泌系统长期过度激活是慢性心力衰竭进行性恶化的重要原因,抑制交感神经系统和肾素-血管紧张素-醛固酮系统(RAAS)的过度激活是慢性心力衰竭治疗的关键,醛固酮拮抗剂是继血管紧张素转换酶抑制剂(ACEI)和β受体阻滞剂之后第三个能够降低心力衰竭患者病死率的药物。
出处
《中国医刊》
CAS
2012年第6期23-25,共3页
Chinese Journal of Medicine
参考文献12
-
1Rochar F. Williams GH. Rationale for the use Aldosterone antagonists in congestive heart failure [ J ]. Drugs,2002,62 ( 5 ) : 723 - 731.
-
2Foo RS,Mani K, Kitsis RN. Death begets failure in the heart[J]. J Clin Invest,2005,115 (3) : 365.
-
3Davila DF, Nunez TJ, Odrenman R et al. Mechanism of neurohormon- al activation in chronic congestive heart failure:pathophysiology and therapeutic implication [ J ]. Int J Cardio1,2005 ; 101 : 343.
-
4Silvestre JS,Robert V, Heymes C,et al. Myocardial production of al- dostcrone and corticosterone in the rat physiological regulation [ J ]. J Biol Chem, 1998,273 (9) : 4883 - 4891.
-
5Arrogon D, Burger AJ. Neurohumoral activation and ventricular ar- rhythmia in patents with decompensated congestive heart failure:role of endothelin Pacing[J]. Clin Electrophysiol,2003 ;26: 703.
-
6Fritsch NM,Schiffrin EL. Aldosterone:a risk factor for vascular dis- ease[ J]. Curt Hypertens Rep,2003.5 ( 1 ) : 59 - 65.
-
7Staessen J,lijnen P,Fagard R,et al. Rise in plasma concentration of aldosterone during long-term angiotensin suppression [ J ]. Endocri- nology, 1981,91 : 457 - 465.
-
8Weber KT, Brilla OG, pathological hypertrophy and cardiac interstiti- um fibrosis and rennin-angiotensin-aldosterone system [ J ]. Cicula- tion,1991,83 (6) : 1849.
-
9Pitt B, Zannad F, Remme WJ et al. The Randomized Aldactone eval- uation study investigators. The effect of Spironolactone on morbility and mortality in patients with severe heart failure [ J ]. N Engl Meal, 1999 ;341 : 709 - 777.
-
10Pitt B, Remmew J, Zannad F, et al. Epleronone, a selective aldoste- rone blocker in patients with 1 eft ventricular dysfunction after a myo- cardial infarction[ J]. N Engl J Med,2003,348 (14): 1309.
二级参考文献4
-
1Swedberg K, Komajda M, Bohm M, et al. lvahradine and outcomes in chronic heart failure (SHIFF) : a randomised placebo-controlled study. Lancet,2010, 376(9744) :875-885.
-
2Zannad F, McMurray J J, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med ,2011,364 (1) :11-21.
-
3ASCEND-HF study Clinical trial results database:Nesiritide-vasodilatots therapy for heart failure, http://www, trialresuhseenter, org/study7337-ASCENDHF. htm,.
-
4Tong AS, Wells GA, Talajie M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med,2010,363 ( 25 ) : 2385-2395.
共引文献45
-
1张海柱,崔长琮.绝对不应期电刺激对心室肌收缩功能的影响[J].求医问药(下半月刊),2011,9(12):424-425.
-
2李继红,赵红花,石焱.核酪注射液对慢性心力衰竭患者6分钟步行试验距离的影响[J].中国循环杂志,2012,27(2):119-121. 被引量:6
-
3姚建东.血液透析超滤加传统药物治疗顽固性心力衰竭36例体会[J].武警医学院学报,2012,21(7):555-556. 被引量:4
-
4刘正人,王大云,李倏丽,陈将辉.贝那普利联合卡维地洛治疗慢性充血性心力衰竭的疗效观察[J].安徽医药,2012,16(10):1516-1518. 被引量:8
-
5郝素芳,侯翠红,裴娟慧,冉玉琴,张澍,浦介麟.体重指数对慢性心力衰竭患者全因死亡风险的预测作用[J].中国循环杂志,2013,28(1):51-54. 被引量:21
-
6杨丽霞,吕晋琳,齐峰,叶金善,郭瑞威,石燕昆.外周血肿瘤坏死因子-α信使核糖核酸表达及与核因子-κB活化与慢性心力衰竭严重程度的临床研究[J].中国循环杂志,2013,28(2):122-124. 被引量:4
-
7滕攀,马琍.慢性心力衰竭中西医治疗进展[J].江西中医药,2013,44(5):71-74. 被引量:14
-
8张新文,李三潭,张源祥,贾国良,雷婷,陈晨,夏天,黄武光,李欣蔚,李忠信.抗凝治疗对心力衰竭患者长期预后的影响研究[J].实用心脑肺血管病杂志,2013,21(10):22-24. 被引量:2
-
9刘蕊,卜丽梅.老年慢性心力衰竭的治疗进展[J].中国老年学杂志,2013,33(23):6059-6061. 被引量:42
-
10佟翠艳,何瑞,李春辉.老年慢性心力衰竭临床特点及药物治疗分析[J].中国医药导报,2014,11(9):57-61. 被引量:55
同被引文献36
-
1曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
-
2马虹.重组人类脑钠肽在心力衰竭治疗中的作用[J].新医学,2007,38(10):685-687. 被引量:25
-
3胡大一,严晓伟.β肾上腺素能受体阻滞剂的规范使用.北京:人民卫生出版社,2009:223-254.
-
4McNamara DM.Pharmacogenomics for neurohormonal intervention in heart failure.Cardiol Clin,2008,26(1):127-135,viii.
-
5Braunwald E.Expanding indications for beta-blockers in heart failure.N Engl J Med,2001,344(22):1711-1712.
-
6中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2007,12(35):1076-1095.
-
7Hunt SA,Baker DW, Chin MH,et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the aduh:a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guide lines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) [J]. Circulation, 2001, 104(24) :2996-3007.
-
8Hunt SA,Abraham WT,Chin MH,et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 200l Guidelines for the Evaluation and Management of Heart Failure) :Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:Endorsed by the Heart Rhythm Society [J]. Circulation, 2005,112 ( 12 ) : 154-235.
-
9Hunt SA,Abraham WT,Chin MH,et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in aduhs:a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide lines [J]. J Am Coil Cardio1,2009,53 (15):1-90.
-
10Yancy CW,Jessup M,Bozkurt B,et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2013,128 (16) : 240-319.
引证文献4
-
1曾祥琴,王菲菲.比索洛尔治疗慢性收缩性心力衰竭的临床观察[J].中国医药,2013,8(12):1693-1694. 被引量:1
-
2佟翠艳,何瑞,李春辉.老年慢性心力衰竭临床特点及药物治疗分析[J].中国医药导报,2014,11(9):57-61. 被引量:55
-
3张彦军,魏萍.慢性心力衰竭的临床特点及药物治疗回顾性分析[J].卫生职业教育,2016,34(16):103-105. 被引量:5
-
4罗磊,张怡.呋塞米联合依那普利治疗慢性心力衰竭的临床效果[J].临床医学研究与实践,2018,3(34):31-32. 被引量:2
二级引证文献61
-
1陈建涛.酒石酸美托洛尔片联合心脉隆注射液治疗慢性心力衰竭的临床效果[J].慢性病学杂志,2020(12):1888-1889. 被引量:1
-
2吉晓丽.卡维地洛对慢性心力衰竭患者心功能及神经内分泌的影响[J].社区医学杂志,2015,13(6):21-22.
-
3刘旭帮,魏娟玲.卡维地洛对老年慢性心力衰竭患者心功能的影响[J].中国伤残医学,2015,23(12):94-95.
-
4崔耿,徐华,黎伟强.内科老年重症心力衰竭的治疗方案分析[J].山西医药杂志,2015,44(8):855-857. 被引量:7
-
5宋玉新,李莉,赵碧琼.华法林联合毛花苷C治疗老年扩张型心肌病的临床观察[J].中国生化药物杂志,2015,35(5):95-97. 被引量:4
-
6龙岩,周宗华,周承操.托拉塞米与呋塞米对慢性心力衰竭治疗效果的比较[J].中国医药科学,2015,5(9):85-87. 被引量:4
-
7李亚美,丁春晖.氯沙坦对急性心力衰竭患者的疗效及超敏C反应蛋白和血清肌钙蛋白T的影响[J].中国医药科学,2015,5(20):40-42.
-
8杨红玲,孙焱,刘帆,肖本胜,沈志强.叶酸和维生素B_(12)辅助治疗老年慢性心力衰竭120例临床观察[J].中国民族民间医药,2016,25(3):116-119. 被引量:1
-
9王建英,仵淑娟,伊利伟,蒋广超.稳心颗粒联合西药对老年慢性心力衰竭患者血浆AngⅡ、NT-proBNP及心功能的影响[J].现代中西医结合杂志,2016,25(7):725-728. 被引量:20
-
10曹刚,全红,钟德福,朱明古,高少虎,陈改义.螺内酯治疗急性心肌梗死后心力衰竭的效果及骨桥蛋白的变化[J].中国医药导报,2016,13(6):161-165. 被引量:4
-
1如何应用降糖药?[J].糖尿病新世界,2006(3):54-54.
-
2郭随章.你了解胃肠动力药吗[J].家庭医学(上半月),2004(21):26-26.
-
3孙娟,曹春和,曹春霞.2型糖尿病患者如何应用胰岛素[J].中国实用医药,2010,5(10):122-123. 被引量:3
-
4程莹莹,郑文妹.如何应用心理干预对糖尿病足病人产生影响[J].中国伤残医学,2009,17(6):161-162. 被引量:1
-
5郑秋甫.心力衰竭[J].中华保健医学杂志,2009,11(1):78-80.
-
6郭从容.中西医结合治疗糖尿病肾病40例临床观察[J].河南中医学院学报,2003,18(3):54-55. 被引量:4
-
7陈欣,林江涛.传染性非典型肺炎治疗中肾上腺皮质激素应用的有关问题[J].新医学,2005,36(3):138-139. 被引量:2
-
8张宝英,张丽华.在脂肪肝诊断中如何应用血清铁蛋白[J].中国保健,2009(32):1523-1523.
-
9冯剑,李志芳,张顺涛.冠心病介入治疗围手术期的抗栓治疗进展[J].中国医疗前沿,2008,3(15):37-39. 被引量:3
-
10刘国荣.什么情况可用纯蛋白餐?[J].糖尿病之友,2005(2):53-53.